Phase I single-dose trial of FX-125L in volunteers.

Trial Profile

Phase I single-dose trial of FX-125L in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Dec 2009

At a glance

  • Drugs FX 125L (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease; Inflammatory bowel diseases; Psoriasis; Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Funxional Therapeutics
  • Most Recent Events

    • 21 Dec 2009 Results were presented at the 2009 Annual Meeting of the American College of Allergy, Asthma and Immunology.
    • 13 Jul 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top